Clinical Trials Details

Breast Cancer

A Phase 2, multicenter, randomized, open-label study comparing eribulin mesylate and ixabepilone in causing or exacerbating neuropathy in patients with advanced breast cancer

Trial ID: 08077

Contact: Carolyn Cox

Phone: (281)863-6641

Learn More about this trial.

go back | new search

This Study is currently being offered at the following Sites:

Practice	State/City
Texas Oncology, P.A.	Bedford, TX (Harris HEB)
Maryland Hematology/Oncology Associates, P.A.	Columbia (Charter), MD
Texas Oncology, P.A.	Dallas, TX (Medical City)
Texas Oncology, P.A.	Dallas, TX (Presbyterian)
Texas Oncology, P.A.	Dallas, TX (Sammons CC)
Texas Oncology, P.A.	Houston, TX (Frostwood)
Virginia Oncology Associates	Newport News, VA
Virginia Oncology Associates	Norfolk, VA (Lake Wright)
Ocala Oncology Center, P.L.	Ocala, FL
Texas Oncology, P.A.	Plano, TX (East)
Northwest Cancer Specialists, P.C.	Portland, OR (Broadway)
Northwest Cancer Specialists, P.C.	Portland, OR (Hoyt)
Raleigh Hematology Oncology Associates, P.C.	Raleigh, NC
Arizona Oncology Associates, PC - NAHOA	Sedona, AZ
Northwest Cancer Specialists, P.C.	Tualatin, OR
Texas Oncology, P.A.	Tyler, TX
Northwest Cancer Specialists, P.C.	Vancouver, WA (134th St)
Northwest Cancer Specialists, P.C.	Vancouver, WA (136th Ave)
Virginia Oncology Associates	Virginia Beach, VA